/biz/ - Business & Finance

So, the biotech sector only recently stood to retake valuations from the 2015 era (one of the most notorious recent bubbles that popped, strongly recommend you guys look up 2015 biotech bubble and read some stories) We had a tremendous degree of advancement in the field, along with earnings almost doubling from that year to now.

Are these valuations a bubble once more? I feel skeptical of a serious bear market occuring at pre bubble valuations in 2018, but broad market vol’ is pretty serious threat.